Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
BIDU-SW
09888
US Stock MarketDetailed Quotes
Artelo Biosciences (ARTL)
- 1.846
- -0.114-5.83%
Trading Nov 12 14:40 ET
3.69MMarket Cap-0.10P/E (TTM)
1.959High1.750Low106.10KVolume1.900Open1.960Prev Close193.79KTurnover5.34%Turnover RatioLossP/E (Static)2.00MShares28.60052wk High-2.62P/B3.67MFloat Cap1.66052wk Low--Dividend TTM1.99MShs Float450.000Historical High--Div Yield TTM10.67%Range %1.660Historical Low1.826Avg Price1Lot Size
About Artelo Biosciences Company
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Company Profile
SymbolARTL
Company NameArtelo Biosciences
Listing DateJun 21, 2019
ISINUS04301G6070
Founded2011
CEOMr. Gregory D. Gorgas
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address505 Lomas Santa Fe,Suite 160
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-7049
Websitehttp://www.artelobio.com
Company Executives
- Name
- Position
- Salary
- Gregory D. Gorgas
- Director, President, Chief Executive Officer and Secretary
- 1.06M
- Mark E. Spring
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Connie L. Matsui
- Chairman of the Board
- 88.51K
- Tamara A. Favorito
- Independent Director
- 63.25K
- Steven Kelly
- Independent Director
- 70.46K
- Dr. R. Martin Emanuele, PhD
- Independent Director
- 54.14K
- Dr. Gregory R. Reyes, M.D.,PhD
- Independent Director
- 50.63K
- Dr. Douglas Blayney, M.D.
- Independent Director
- 58.45K
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?